Bill to Eliminate Cancer Drugs from Sequester Gaining Strength
After a recent hearing by the House Energy and Commerce Health Subcommittee, the Cancer Patient Protection Act of 2013 (HR 1416) is gaining support. The bi-partisan bill was introduced by Congresswoman Renee Ellmers and now enjoys 97 co-sponsors.
Our fight is not over, however. ACCC continues to educate other members of the House about the importance of this legislation. ACCC recently met with Representative Erik Paulsen’s office, who is one of the latest members to sign onto HR 1416. We are continuing to work to identify a champion in the Senate.
HR 1416 would restore Medicare reimbursement for anti-cancer drugs and biologicals to pre-sequester levels. Currently, the 2% sequester applies to everything billed to Medicare, including the reimbursement for anti-cancer drugs. Due to the high cost of cancer drugs, oncology is being disproportionally affected by the 2% across-the-board sequester on Medicare payments. As increased support for HR 1416 shows, that message is being understood.
As support grows for this critical legislation, take a moment to thank the members of Congress who have signed on as co-sponsors. If your representative is listed here, please make a quick call to say thank you for his or her commitment to cancer care.
As always, we thank you for your continued outreach and ACCC will keep you updated on further developments.